{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:36:34Z","timestamp":1760099794408},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf02245250","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T13:49:48Z","timestamp":1132062588000},"page":"57-64","source":"Crossref","is-referenced-by-count":7,"title":["Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats"],"prefix":"10.1007","volume":"118","author":[{"given":"A. J.","family":"Goudie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Leathley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245250_CR1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02247359","volume":"112","author":"N Andrews","year":"1993","unstructured":"Andrews N, File SE (1993) Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence. Psychopharmacology 112:21\u201325","journal-title":"Psychopharmacology"},{"key":"BF02245250_CR2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0361-9230(88)90219-5","volume":"20","author":"HA Baldwin","year":"1988","unstructured":"Baldwin HA, File SE (1988) Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull 20:603\u2013606","journal-title":"Brain Res Bull"},{"key":"BF02245250_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0091-3057(91)90326-W","volume":"40","author":"NM Barnes","year":"1991","unstructured":"Barnes NM, Costall B, Domeney AM, Gerrard PA, Kelly ME, Khraling H, Naylor RJ, Tompkins DM, Williams TJ (1991) The effects of umespirone as a potential anxiolytic and antipsychotic agent. Pharmacol Biochem Behav 40:89\u201396","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245250_CR4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/312363a0","volume":"312","author":"J Bradwejn","year":"1984","unstructured":"Bradwejn J, De Montigny C (1984) Benzodiazepines antagonise cholecystokinin-induced activation of rat hippocampal neurones. Nature 312:363\u2013364","journal-title":"Nature"},{"key":"BF02245250_CR5","first-page":"383","volume-title":"Behavioural pharmacology of 5-HT","author":"B Costall","year":"1989","unstructured":"Costall B, Domeney AM, Gerrard PA, Jones BJ, Kelley ME, Oakley NR, Tyers MB (1989a) The anxiolytic activities of the 5-HT3 receptor antagonists GR38032F, ICS 205-930 and BRL 43694. In: Bevan P, Cools AR, Archer T (eds) Behavioural pharmacology of 5-HT. Lawrence Erlbaum Associates, Hillsdale, New Jersey, p 383"},{"key":"BF02245250_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0091-3057(89)90273-6","volume":"34","author":"B Costall","year":"1989","unstructured":"Costall B, Jones BJ, Kelly ME, Naylor RJ, Oakley NR, Onaivi ES, Tyers MB (1989b) The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol Biochem Behav 34:769\u2013778","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245250_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0091-3057(90)90118-2","volume":"36","author":"B Costall","year":"1990","unstructured":"Costall B, Domeney AM, Gerrard PA, Horrovitz ZP, Kelly ME, Naylor RJ, Tompkins DM (1990a) Effects of captropil and SQ,29,852 on anxiety-related behaviours in rodent and marmoset. Pharmacol Biochem Behav 36:13\u201320","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245250_CR8","first-page":"547","volume":"341","author":"B Costall","year":"1990","unstructured":"Costall B, Kelly ME, Naylor RJ, Onaivi ES (1990b) The effects of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse. Naunyn Schmeideberg's Ach Pharmacol 341:547\u2013551","journal-title":"Naunyn Schmeideberg's Ach Pharmacol"},{"key":"BF02245250_CR9","first-page":"90","volume":"262","author":"B Costall","year":"1992","unstructured":"Costall B, Domeney AM, Farre AJ, Kelly ME, Martinez L, Naylor RJ (1992) Profile of action of the novel 5-HT1A receptor ligand E-4424 to inhibit aversive behaviour in the mouse, rat and marmoset. J Pharmacol Exp Ther 262:90\u201398","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245250_CR10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02244893","volume":"112","author":"DJ Dooley","year":"1993","unstructured":"Dooley DJ, Klamt I (1993) Differential profile of the CCKB antagonist CI988 and diazepam in the four-plate test. Psychopharmacology 112:452\u2013454","journal-title":"Psychopharmacology"},{"key":"BF02245250_CR11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.2781294","volume":"245","author":"CT Dourish","year":"1989","unstructured":"Dourish CT, Rycroft W, Iversen SD (1989) Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors. Science 245:1509\u20131511","journal-title":"Science"},{"key":"BF02245250_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(90)90129-T","volume":"176","author":"CT Dourish","year":"1990","unstructured":"Dourish CT, O'Neill MF, Coughlan J, Kitchener SJ, Hawley D, Iversen SD (1990) The selective CCK B receptor antagonist L-365, 260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur J Pharmacol 176:35\u201344","journal-title":"Eur J Pharmacol"},{"key":"BF02245250_CR13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/BF02244384","volume":"105","author":"SE File","year":"1991","unstructured":"File SE, Andrews N (1991) Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal. Psychopharmacolgy 105:578\u2013582","journal-title":"Psychopharmacolgy"},{"key":"BF02245250_CR14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02244555","volume":"104","author":"SE File","year":"1991","unstructured":"File SE, Mabbutt PS, Andrews N (1991) Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen. Psychopharmacology 104:62\u201366","journal-title":"Psychopharmacology"},{"key":"BF02245250_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(90)90638-M","volume":"185","author":"AJ Goudie","year":"1990","unstructured":"Goudie AJ, Leathley MJ (1990) Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats. Eur J Pharmacol 185:179\u2013184","journal-title":"Eur J Pharmacol"},{"key":"BF02245250_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF02244254","volume":"103","author":"AJ Goudie","year":"1991","unstructured":"Goudie AJ, Leathley MJ (1991a) An evaluation of the dependence potential of the selective 5-HT1A agonist ipsapirone in rats and its effects on benzodiazepine withdrawal. Psychopharmacology 103:529\u2013537","journal-title":"Psychopharmacology"},{"key":"BF02245250_CR17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00008877-199112000-00003","volume":"2","author":"AJ Goudie","year":"1991","unstructured":"Goudie AJ, Leathley MJ (1991b) Effects of the 5-HT1A agonist gepirone on benzodiazepine withdrawal in rats. Behav Pharmacol 2:461\u2013469","journal-title":"Behav Pharmacol"},{"key":"BF02245250_CR18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF02247724","volume":"109","author":"AJ Goudie","year":"1992","unstructured":"Goudie AJ, Leathley MJ (1992) Operant \u201cbehavioural dependence\u201d studies with chlordiazepoxide in rats: lack of effect of ondansetron. Psychopharmacology 109:461\u2013465","journal-title":"Psychopharmacology"},{"key":"BF02245250_CR19","doi-asserted-by":"crossref","unstructured":"Goudie AJ, Leathley MJ (1994) Assessment of the dependence potential of the potent high-efficacy 5-HT1A agonist anxiolytic S-14506 in rats. J Psychopharmacology (in press)","DOI":"10.1177\/026988119400800404"},{"key":"BF02245250_CR20","first-page":"295","volume":"4","author":"AJ Goudie","year":"1993","unstructured":"Goudie AJ, Harrison AA, Leathley MJ (1993) Evidence for a dissociation between benzodiazepine withdrawal signs. Neuro Report 4: 295\u2013298","journal-title":"Neuro Report"},{"key":"BF02245250_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008877-199404000-00004","volume":"5","author":"AJ Goudie","year":"1994","unstructured":"Goudie AJ, Leathley MJ, Cowgill J (1994) Assessment of the benzodiazepine-like dependence potential of the putative 5-HT1A agonist anxiolytic S-20499 in rats. Behav Pharmacol 5: 131\u2013140","journal-title":"Behav Pharmacol"},{"key":"BF02245250_CR22","first-page":"62","volume":"341","author":"J Harro","year":"1990","unstructured":"Harro J, Pold M, Vasar E (1990a) Anxiogenic-like actions of caerulein, a CCK-8 receptor agonist, in the mouse. Influence of acute and subchronic diazepam treatment. Naunyn-Schmiedeberg's Arch Pharmacol 341: 62\u201367","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02245250_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-2999(90)90594-V","volume":"180","author":"J Harro","year":"1990","unstructured":"Harro J, Lang A, Vasar E (1990b) Long term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain. Eur J Pharmacol 180: 77\u201383","journal-title":"Eur J Pharmacol"},{"key":"BF02245250_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0166-4328(90)90121-T","volume":"39","author":"J Harro","year":"1990","unstructured":"Harro J, Kiivet R-A, Lang A, Vasar E (1990c) Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav Brain Res 39: 63\u201371","journal-title":"Behav Brain Res"},{"key":"BF02245250_CR25","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1073\/pnas.87.17.6728","volume":"87","author":"J Hughes","year":"1990","unstructured":"Hughes J, Boden P, Costall B, Domeney AM, Kelly ME, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN (1990) Development of a new class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA. 87: 6728\u20136732","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02245250_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00008877-199203010-00008","volume":"3","author":"MJ Leathley","year":"1992","unstructured":"Leathley MJ, Goudie AJ (1992) Effects of the 5-HT3 antagonist ICS 205\u2013930 on benzodiazepine withdrawal in rats. Behav Pharmacol 3: 51\u201356","journal-title":"Behav Pharmacol"},{"key":"BF02245250_CR27","first-page":"247","volume":"4","author":"MJ Leathley","year":"1993","unstructured":"Leathley MJ, Goudie AJ (1993) Effects of the 5-HT2 antagonist ritanserin on benzodiazepine withrawal-induced weight loss in rats. Behav Pharmacol 4: 247\u2013255","journal-title":"Behav Pharmacol"},{"key":"BF02245250_CR28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(89)90290-2","volume":"162","author":"VJ Lotti","year":"1989","unstructured":"Lotti VJ, Chang RSL (1989) A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCKB) ligand: L 365, 260. Eur J Pharmacol 162: 273\u2013280","journal-title":"Eur J Pharmacol"},{"key":"BF02245250_CR29","first-page":"149","volume":"3","author":"TF Meert","year":"1992","unstructured":"Meert TF (1992) Ritanserin overcomes exploratory inhibition induced by cocaine withdrawal. Behav Pharmacol 3: 149\u2013154","journal-title":"Behav Pharmacol"},{"key":"BF02245250_CR30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0091-3057(93)90537-4","volume":"45","author":"AK Mehta","year":"1993","unstructured":"Mehta AK, Ticku MJ (1993) Ethanol-and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation. Pharmacol Biochem Behav 45: 755\u2013757","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl","key":"BF02245250_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0143-4179(91)90085-W","volume":"19","author":"KR Powell","year":"1991","unstructured":"Powell KR, Barrett JE (1991) Evaluation of the effects of PD1343078 (CI-988), a CCK B antagonist, on the punished responding of squirrel monkeys. Neuropeptides 19 [Suppl]: 75\u201378","journal-title":"Neuropeptides"},{"key":"BF02245250_CR32","first-page":"622","volume":"264","author":"Pl Prather","year":"1993","unstructured":"Prather Pl, Rezazadeh SM, Lane JD, Rowan GA, Hooper ML, Lytle DA, Emmett-Oglesby MW, Lal H (1993) Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal. J Pharmacol Exp Ther 264: 622\u2013630","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245250_CR33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00001756-199311180-00015","volume":"5","author":"K Rasmussen","year":"1993","unstructured":"Rasmussen K, Helton DR, Berger JE, Scearce E (1993) The CCK B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. NeuroReport 5: 154\u2013156","journal-title":"NeuroReport"},{"key":"BF02245250_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(91)91139-R","volume":"548","author":"J Rataud","year":"1991","unstructured":"Rataud J, Darche F, Piot O, Stutzman JM, Bohme GA, Blanchard J (1991) Anxiolytic effects of CCK-antagonists on plus maze behaviour in mice. Brain Res 548: 1\u20132","journal-title":"Brain Res"},{"key":"BF02245250_CR35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-6147(90)90004-R","volume":"11","author":"S Ravard","year":"1990","unstructured":"Ravard S, Dourish CT (1990) Cholecystokinin and anxiety. Trends Pharmacol Sci 11: 271\u2013273","journal-title":"Trends Pharmacol Sci"},{"key":"BF02245250_CR36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1073\/pnas.88.4.1130","volume":"88","author":"L Singh","year":"1991","unstructured":"Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN (1991a) Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA 88: 1130\u20131133","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02245250_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1476-5381.1991.tb12413.x","volume":"104","author":"L Singh","year":"1991","unstructured":"Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, Woodruff GN (1991b) The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist. Br J Pharmacol 104: 239\u2013245","journal-title":"Br J Pharmacol"},{"key":"BF02245250_CR38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1476-5381.1992.tb14201.x","volume":"105","author":"L Singh","year":"1992","unstructured":"Singh L, Field MJ, Vass CA, Hughes J, Woodruff GN (1992) Antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988. Br J Pharmacol 105: 8\u201310","journal-title":"Br J Pharmacol"},{"key":"BF02245250_CR39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF02245450","volume":"114","author":"JA Vivian","year":"1994","unstructured":"Vivian JA, Farrell WJ, Sapperstein SB, Miczek KA (1994) Diazepam withdrawal: effects of diazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalisations. Psychopharmacology 114: 101\u2013108","journal-title":"Psychopharmacology"},{"key":"BF02245250_CR40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pa.31.040191.002345","volume":"31","author":"GN Woodruff","year":"1991","unstructured":"Woodruff GN, Hughes J (1991) Cholecystokinin antagonists. Annu Rev Pharmacol Toxicol 31: 469\u2013501","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245250\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:18Z","timestamp":1557941598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF02245250"],"URL":"https:\/\/doi.org\/10.1007\/bf02245250","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}